We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Radcal

Download Mobile App




Lab-on-a-Patch Enables Continuous and Real-Time Monitoring of Multiple Disease Biomarkers

By HospiMedica International staff writers
Posted on 08 Jun 2023
Print article
Image: A breakthrough technology combines multiple DNA sensors with microneedles (Photo courtesy of Nutromics)
Image: A breakthrough technology combines multiple DNA sensors with microneedles (Photo courtesy of Nutromics)

Advancements in continuous glucose monitors (CGMs) have significantly improved the management of diabetes, however, they come with a major shortcoming: CGMs are incapable of measuring any diagnostic target other than glucose. Now, DNA-based sensing has emerged as a breakthrough technology that overcomes this limitation with its ability to enable continuous and real-time measurements of any diagnostic target.

Nutromics’ (Melbourne, Australia) is developing a "lab-in-a-patch" that harnesses DNA sensor technology to track various targets such as disease biomarkers and difficult-to-administer drugs within the human body. Currently undergoing in-human trial testing, Nutromics' DNA-based sensor platform is poised to bring about a significant shift in diagnostic methods. By integrating multiple DNA-based sensors with minimally invasive microneedles, the platform allows for continual and real-time tracking of various vital targets. With its aptamer platform, Nutromics stands to improve the prognosis for millions of patients in clinically critical conditions. By offering medical practitioners the ability to continuously monitor a wide array of analytes that presently cannot be analyzed in real-time, Nutromics’ "lab-in-a-patch could become a game changer in various clinical situations.

The initial product to come out from Nutromics’ stable is a wearable device equipped with a vancomycin sensor. Vancomycin, a potent antibiotic used for treating severe infections like sepsis, presents a dosage challenge due to its narrow therapeutic window, high toxicity, and limited patient blood level data available to doctors. DNA-based sensors can overcome these hurdles by providing continuous, real-time information on vancomycin concentration levels, enabling doctors to calibrate the antibiotic dosage to maintain the therapeutic range and avoid toxicity. Additionally, DNA-based sensors can significantly influence heart attack diagnosis. Troponin, a protein that markedly increases in the bloodstream upon heart muscle damage (like during a heart attack), can be continuously monitored to provide early trend data. This could drastically reduce heart attack diagnosis time to mere minutes, ultimately saving lives. Nutromics envisions a future where DNA-based biosensors extend beyond acute hospital settings to point-of-care, general lab testing, and even consumer use for the prevention of disease among healthy individuals.

Related Links:
Nutromics 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Antegrade Femoral Nailing System
AUTOBAHN EVO

Print article

Channels

Surgical Techniques

view channel
Image: New studies suggest benefit of total robotic metabolic and bariatric surgery over conventional laparoscopy (Photo courtesy of 123RF)

Total Robotic Metabolic and Bariatric Surgery Proves More Beneficial than Conventional Laparoscopy

According to the U.S. Centers for Disease Control and Prevention (CDC), 42.4% of Americans are affected by obesity. Research indicates that obesity can compromise the immune system, trigger chronic inflammation,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.